NIH consensus development conference statement

Lactose intolerance and health.

Frederick J. Suchy, Patsy M. Brannon, Thomas O. Carpenter, Jose R. Fernandez, Vicente Gilsanz, Jeffrey B. Gould, Karen Hall, Siu Hui, Joanne Lupton, Julie Mennella, Natalie J. Miller, Stavroula Kalis Osganian, Deborah E. Sellmeyer, Marshall A. Wolf

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

To provide health care providers, patients, and the general public with a responsible assessment of currently available data on lactose intolerance and health. A non-DHHS, nonadvocate 14-member panel representing the fields of internal medicine, pediatrics, pediatric and adult endocrinology, gastroenterology, hepatology, neonatology and perinatology, geriatrics, racial/ethnic disparities, radiology, maternal and fetal nutrition, vitamin and mineral metabolism, nutritional sciences, bone health, preventive medicine, biopsychology, biostatistics, statistical genetics, epidemiology, and a public representative. In addition, 22 experts from pertinent fields presented data to the panel and conference audience. Presentations by experts and a systematic review of the literature prepared by the University of Minnesota Evidence-based Practice Center, through the Agency for Healthcare Research and Quality. Scientific evidence was given precedence over anecdotal experience. The panel drafted its statement based on scientific evidence presented in open forum and on published scientific literature. The draft statement was presented on the final day of the conference and circulated to the audience for comment. The panel released a revised statement later that day at http://consensus.nih.gov. This statement is an independent report of the panel and is not a policy statement of the NIH or the Federal Government. • Lactose intolerance is a real and important clinical syndrome, but its true prevalence is not known. • The majority of people with lactose malabsorption do not have clinical lactose intolerance. Many individuals who think they are lactose intolerant are not lactose malabsorbers. • Many individuals with real or perceived lactose intolerance avoid dairy and ingest inadequate amounts of calcium and vitamin D, which may predispose them to decreased bone accrual, osteoporosis, and other adverse health outcomes. In most cases, individuals do not need to eliminate dairy consumption completely. • Evidence-based dietary approaches with and without dairy foods and supplementation strategies are needed to ensure appropriate consumption of calcium and other nutrients in lactose-intolerant individuals. • Educational programs and behavioral approaches for individuals and their healthcare providers should be developed and validated to improve the nutrition and symptoms of individuals with lactose intolerance and dairy avoidance.

Original languageEnglish (US)
Pages (from-to)1-27
Number of pages27
JournalNIH consensus and state-of-the-science statements
Volume27
Issue number2
StatePublished - Feb 24 2010
Externally publishedYes

Fingerprint

NIH Consensus Development Conferences
Lactose Intolerance
Health
Lactose
Gastroenterology
Health Personnel
Perinatology
Nutritional Sciences
Biostatistics
Pediatrics
Calcium
Neonatology
Literature
Bone and Bones
Federal Government
Preventive Medicine
Molecular Epidemiology
Endocrinology
Evidence-Based Practice
Health Services Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Suchy, F. J., Brannon, P. M., Carpenter, T. O., Fernandez, J. R., Gilsanz, V., Gould, J. B., ... Wolf, M. A. (2010). NIH consensus development conference statement: Lactose intolerance and health. NIH consensus and state-of-the-science statements, 27(2), 1-27.

NIH consensus development conference statement : Lactose intolerance and health. / Suchy, Frederick J.; Brannon, Patsy M.; Carpenter, Thomas O.; Fernandez, Jose R.; Gilsanz, Vicente; Gould, Jeffrey B.; Hall, Karen; Hui, Siu; Lupton, Joanne; Mennella, Julie; Miller, Natalie J.; Osganian, Stavroula Kalis; Sellmeyer, Deborah E.; Wolf, Marshall A.

In: NIH consensus and state-of-the-science statements, Vol. 27, No. 2, 24.02.2010, p. 1-27.

Research output: Contribution to journalArticle

Suchy, FJ, Brannon, PM, Carpenter, TO, Fernandez, JR, Gilsanz, V, Gould, JB, Hall, K, Hui, S, Lupton, J, Mennella, J, Miller, NJ, Osganian, SK, Sellmeyer, DE & Wolf, MA 2010, 'NIH consensus development conference statement: Lactose intolerance and health.', NIH consensus and state-of-the-science statements, vol. 27, no. 2, pp. 1-27.
Suchy FJ, Brannon PM, Carpenter TO, Fernandez JR, Gilsanz V, Gould JB et al. NIH consensus development conference statement: Lactose intolerance and health. NIH consensus and state-of-the-science statements. 2010 Feb 24;27(2):1-27.
Suchy, Frederick J. ; Brannon, Patsy M. ; Carpenter, Thomas O. ; Fernandez, Jose R. ; Gilsanz, Vicente ; Gould, Jeffrey B. ; Hall, Karen ; Hui, Siu ; Lupton, Joanne ; Mennella, Julie ; Miller, Natalie J. ; Osganian, Stavroula Kalis ; Sellmeyer, Deborah E. ; Wolf, Marshall A. / NIH consensus development conference statement : Lactose intolerance and health. In: NIH consensus and state-of-the-science statements. 2010 ; Vol. 27, No. 2. pp. 1-27.
@article{aa05299963c14741baa1da9ccb97fe95,
title = "NIH consensus development conference statement: Lactose intolerance and health.",
abstract = "To provide health care providers, patients, and the general public with a responsible assessment of currently available data on lactose intolerance and health. A non-DHHS, nonadvocate 14-member panel representing the fields of internal medicine, pediatrics, pediatric and adult endocrinology, gastroenterology, hepatology, neonatology and perinatology, geriatrics, racial/ethnic disparities, radiology, maternal and fetal nutrition, vitamin and mineral metabolism, nutritional sciences, bone health, preventive medicine, biopsychology, biostatistics, statistical genetics, epidemiology, and a public representative. In addition, 22 experts from pertinent fields presented data to the panel and conference audience. Presentations by experts and a systematic review of the literature prepared by the University of Minnesota Evidence-based Practice Center, through the Agency for Healthcare Research and Quality. Scientific evidence was given precedence over anecdotal experience. The panel drafted its statement based on scientific evidence presented in open forum and on published scientific literature. The draft statement was presented on the final day of the conference and circulated to the audience for comment. The panel released a revised statement later that day at http://consensus.nih.gov. This statement is an independent report of the panel and is not a policy statement of the NIH or the Federal Government. • Lactose intolerance is a real and important clinical syndrome, but its true prevalence is not known. • The majority of people with lactose malabsorption do not have clinical lactose intolerance. Many individuals who think they are lactose intolerant are not lactose malabsorbers. • Many individuals with real or perceived lactose intolerance avoid dairy and ingest inadequate amounts of calcium and vitamin D, which may predispose them to decreased bone accrual, osteoporosis, and other adverse health outcomes. In most cases, individuals do not need to eliminate dairy consumption completely. • Evidence-based dietary approaches with and without dairy foods and supplementation strategies are needed to ensure appropriate consumption of calcium and other nutrients in lactose-intolerant individuals. • Educational programs and behavioral approaches for individuals and their healthcare providers should be developed and validated to improve the nutrition and symptoms of individuals with lactose intolerance and dairy avoidance.",
author = "Suchy, {Frederick J.} and Brannon, {Patsy M.} and Carpenter, {Thomas O.} and Fernandez, {Jose R.} and Vicente Gilsanz and Gould, {Jeffrey B.} and Karen Hall and Siu Hui and Joanne Lupton and Julie Mennella and Miller, {Natalie J.} and Osganian, {Stavroula Kalis} and Sellmeyer, {Deborah E.} and Wolf, {Marshall A.}",
year = "2010",
month = "2",
day = "24",
language = "English (US)",
volume = "27",
pages = "1--27",
journal = "NIH consensus and state-of-the-science statements",
issn = "1553-0957",
publisher = "US Department of Health and Human Services",
number = "2",

}

TY - JOUR

T1 - NIH consensus development conference statement

T2 - Lactose intolerance and health.

AU - Suchy, Frederick J.

AU - Brannon, Patsy M.

AU - Carpenter, Thomas O.

AU - Fernandez, Jose R.

AU - Gilsanz, Vicente

AU - Gould, Jeffrey B.

AU - Hall, Karen

AU - Hui, Siu

AU - Lupton, Joanne

AU - Mennella, Julie

AU - Miller, Natalie J.

AU - Osganian, Stavroula Kalis

AU - Sellmeyer, Deborah E.

AU - Wolf, Marshall A.

PY - 2010/2/24

Y1 - 2010/2/24

N2 - To provide health care providers, patients, and the general public with a responsible assessment of currently available data on lactose intolerance and health. A non-DHHS, nonadvocate 14-member panel representing the fields of internal medicine, pediatrics, pediatric and adult endocrinology, gastroenterology, hepatology, neonatology and perinatology, geriatrics, racial/ethnic disparities, radiology, maternal and fetal nutrition, vitamin and mineral metabolism, nutritional sciences, bone health, preventive medicine, biopsychology, biostatistics, statistical genetics, epidemiology, and a public representative. In addition, 22 experts from pertinent fields presented data to the panel and conference audience. Presentations by experts and a systematic review of the literature prepared by the University of Minnesota Evidence-based Practice Center, through the Agency for Healthcare Research and Quality. Scientific evidence was given precedence over anecdotal experience. The panel drafted its statement based on scientific evidence presented in open forum and on published scientific literature. The draft statement was presented on the final day of the conference and circulated to the audience for comment. The panel released a revised statement later that day at http://consensus.nih.gov. This statement is an independent report of the panel and is not a policy statement of the NIH or the Federal Government. • Lactose intolerance is a real and important clinical syndrome, but its true prevalence is not known. • The majority of people with lactose malabsorption do not have clinical lactose intolerance. Many individuals who think they are lactose intolerant are not lactose malabsorbers. • Many individuals with real or perceived lactose intolerance avoid dairy and ingest inadequate amounts of calcium and vitamin D, which may predispose them to decreased bone accrual, osteoporosis, and other adverse health outcomes. In most cases, individuals do not need to eliminate dairy consumption completely. • Evidence-based dietary approaches with and without dairy foods and supplementation strategies are needed to ensure appropriate consumption of calcium and other nutrients in lactose-intolerant individuals. • Educational programs and behavioral approaches for individuals and their healthcare providers should be developed and validated to improve the nutrition and symptoms of individuals with lactose intolerance and dairy avoidance.

AB - To provide health care providers, patients, and the general public with a responsible assessment of currently available data on lactose intolerance and health. A non-DHHS, nonadvocate 14-member panel representing the fields of internal medicine, pediatrics, pediatric and adult endocrinology, gastroenterology, hepatology, neonatology and perinatology, geriatrics, racial/ethnic disparities, radiology, maternal and fetal nutrition, vitamin and mineral metabolism, nutritional sciences, bone health, preventive medicine, biopsychology, biostatistics, statistical genetics, epidemiology, and a public representative. In addition, 22 experts from pertinent fields presented data to the panel and conference audience. Presentations by experts and a systematic review of the literature prepared by the University of Minnesota Evidence-based Practice Center, through the Agency for Healthcare Research and Quality. Scientific evidence was given precedence over anecdotal experience. The panel drafted its statement based on scientific evidence presented in open forum and on published scientific literature. The draft statement was presented on the final day of the conference and circulated to the audience for comment. The panel released a revised statement later that day at http://consensus.nih.gov. This statement is an independent report of the panel and is not a policy statement of the NIH or the Federal Government. • Lactose intolerance is a real and important clinical syndrome, but its true prevalence is not known. • The majority of people with lactose malabsorption do not have clinical lactose intolerance. Many individuals who think they are lactose intolerant are not lactose malabsorbers. • Many individuals with real or perceived lactose intolerance avoid dairy and ingest inadequate amounts of calcium and vitamin D, which may predispose them to decreased bone accrual, osteoporosis, and other adverse health outcomes. In most cases, individuals do not need to eliminate dairy consumption completely. • Evidence-based dietary approaches with and without dairy foods and supplementation strategies are needed to ensure appropriate consumption of calcium and other nutrients in lactose-intolerant individuals. • Educational programs and behavioral approaches for individuals and their healthcare providers should be developed and validated to improve the nutrition and symptoms of individuals with lactose intolerance and dairy avoidance.

UR - http://www.scopus.com/inward/record.url?scp=84877930077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877930077&partnerID=8YFLogxK

M3 - Article

VL - 27

SP - 1

EP - 27

JO - NIH consensus and state-of-the-science statements

JF - NIH consensus and state-of-the-science statements

SN - 1553-0957

IS - 2

ER -